{
      "ptx_code": "PTX100",
      "chem_name": "Cytarabine",
      "casrn": "147-94-4",
      "dtxsid": "DTXSID3022877",
      "smiles": "NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O",
      "inchikey": "UHDGCWIWMRVCDJ-CCXZUQQUSA-N",
      "label": "PTX100 | Cytarabine",
      "pubchem_cid": "6253",
      "drugbank_id": "DB00987",
      "use_class": "Pharmaceutical",
      "tox_class": "Neurotoxicity; Cardiotoxicity; Genotoxicity; Hepatotoxicity; Hematotoxicity",
      "formula": "C9H13N3O5",
      "chem_name_user": "Cytosinearabinoside",
      "mw_g_mol": "243.22",
      "solubility_h2o_mol_liter": "0.04",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.34e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.26",
      "source_kaw": "Comptox",
      "pka_acid": "13.7;15.1",
      "pka_base": "4.19",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "-2.32",
      "source_kow": "mean of ACD consensus and KOWWIN",
      "log_dlipw_ph74_liter_liter": "-1.00",
      "source_dlipw": "@ -1 at logKow < -1 (Gobas 1988)",
      "freely_dissolved_fraction": "0.94",
      "density_kg_liter": "1.77",
      "source_density": "COMPTOX",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "212.50",
      "source_melting_point": "CompTox (Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "1620000.00",
      "baseline_dmagna": "216000.00",
      "baseline_celegans": "456359.33",
      "baseline_xlaevis": "31067.05",
      "baseline_dmelanogaster": "2022087.76",
      "baseline_cells": "0.28",
      "baseline_cells_generic_micromole_liter_free_ec10": "0.26",
      "moa_drugbank": "Cytarabine acts through direct DNA damage and incorporation into DNA. Cytarabine is cytotoxic to a wide variety of proliferating mammalian cells in culture. It exhibits cell phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions blocking the progression of cells from the G1 phase to the S-phase. Although the mechanism of action is not completely understood, it appears that cytarabine acts through the inhibition of DNA polymerase. A limited, but significant, incorporation of cytarabine into both DNA and RNA has also been reported.",
      "protein_binding": "13%",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            }
      ],
      "targets": [
            "DNA polymerase beta",
            "Deoxycytidine kinase"
      ]
}